10x Genomics Enters Research Collaboration With Fred Hutchinson Cancer Center
MT newswire2026/10/07 13:5809:58 AM EDT, 10/07/2026 (MT Newswires) -- 10x Genomics (TXG) said Wednesday it entered into a multi-project research collaboration with Fred Hutchinson Cancer Center to advance single-cell and spatial technologies across solid tumors and blood cancers. The first project will use 10x's Flex Apex and Xenium platforms to identify biomarkers linked to treatment response and clinical outcomes in patients with advanced bladder cancer, the company said. The second project will use Flex Apex to assess whether single-cell analysis can improve residual disease detection in acute myeloid leukemia after treatment, the company said. 10x Genomics shares were down 7.6% in Wednesday trading. Price: 74.54, Change: -6.12, Percent Change: -7.59
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
SNT Holdings, Related Party Raise Combined Stake in SNTEnergy to 55.75% From 52.75%
Cold wave and rising fuel costs drive electricity prices in northeastern Japan and Tokyo to a four-year high
Japan's spot electricity prices surged to multi-year highs over the weekend.
Google (GOOGL.US) warns that new Australian cybersecurity regulations may cut off minors' access to Gmail
Google stated that a new cybersecurity bill in Australia could prevent minors from using Gmail.
Canaccord Genuity: Lowers Oklo's target price to $66
Crypto prices
More
